JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cruz, I.
Right arrow Articles by Alvar, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cruz, I.
Right arrow Articles by Alvar, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2006, p. 2343-2347, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.02297-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Comparison of New Diagnostic Tools for Management of Pediatric Mediterranean Visceral Leishmaniasis

Israel Cruz,1* Carmen Chicharro,1 Javier Nieto,1 Begoña Bailo,1 Carmen Cañavate,1 María-Concepción Figueras,2 and Jorge Alvar1

WHO Collaborating Centre for Leishmaniasis, Servicio de Parasitología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra. Pozuelo-Majadahonda, km 2, 28220 Majadahonda, Madrid, Spain,1 Hospital Vall d'Hebron, Po. Vall d'Hebron 129, 08035 Barcelona, Spain2

Received 2 November 2005/ Returned for modification 5 January 2006/ Accepted 5 May 2006

New techniques are available for diagnosing leishmaniasis, but their efficacy in the identification of pediatric visceral leishmaniasis (VL) has not been compared with that of traditional methods. Blood, bone marrow, and urine samples were taken from 25 children with VL during their first clinical episode, 22 days after the start of treatment with liposomal amphotericin B (3 mg/kg/day on 6 days over a 10-day period), and when a relapse was suspected during follow-up. The results obtained suggest that antibody detection techniques, the antigen detection in urine (KAtex kit), and Leishmania nested PCR (LnPCR) analysis of the blood could be used for diagnosis of the first clinical episode. After treatment, clinical improvement was associated with negativization of Novy-MacNeal-Nicolle culture and microscopy of bone marrow aspirate, KAtex test, and LnPCR blood analysis results. Interestingly, LnPCR analysis of the bone marrow aspirate showed that sterile cure was not achieved in eight patients, two of which suffered a relapse within 10 to 20 weeks. All of the new noninvasive techniques tested showed high diagnostic sensitivity. However, LnPCR analysis of the bone marrow was the most sensitive; this test was able to detect the persistence of parasites and predict potential relapses.


* Corresponding author. Mailing address: WHO Collaborating Centre for Leishmaniasis, Servicio de Parasitología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra. Pozuelo-Majadahonda km 2, 28220 Majadahonda, Madrid, Spain. Phone: 34 91 822 36 23. Fax: 34 91 509 70 34. E-mail: cruzi{at}isciii.es.


Journal of Clinical Microbiology, July 2006, p. 2343-2347, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.02297-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.